A collaborative study to establish the 3rd international standard for tissue plasminogen activator

Thrombosis and Haemostasis

Volumn 88, Issue 2, 2002, Pages 294-297

  Sands, Dawn ^a   Whitton, Colin M ^a   Merton, R Elizabeth ^a   Longstaff, Colin ^a  

^a Blanche Lane   (United Kingdom)

Author keywords

Collaborative study; International standard; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; FIBRIN; FIBRIN DEGRADATION PRODUCT; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; AUSTRALIA; CALIBRATION; CHO CELL; CONTROLLED STUDY; DEVICE; DRUG POTENCY; ENZYME ACTIVITY; EUROPE; FIBRINOLYSIS; HUMAN; HUMAN CELL; INJECTION; INTERNATIONAL STANDARD UNIT; JAPAN; LABORATORY TEST; MELANOMA CELL; PRIORITY JOURNAL; REFERENCE VALUE; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 0036339951     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613201     Document Type: Article

References (12)

1. A collaborative study to establish the 2nd international standard for tissue plasminogen activator (t-PA)
2. Monograph. Alteplase for injection
3. An automated fibrinolytic assay performed in microtiter plates
4. The roles of alpha 2-anti-plasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis
5. A spectrophotometric solid-phase fibrin-tissue plasminogen activator activity assay (SOFIA-tPA) for high-fibrin-affinity tissue plasminogen activators
6. A new simple and accurate assay for plasminogen activators that may be suitable as a reference method
7. The determination of recombinant human tissue-type plasminogen activator activity by turbidimetry using a microcentrifugal analyzer
8. Geometric means and measure of dispersion
9. Predicting the stability of biological standards and products
10. T-tests and intervals for comparison suggested by the data
11. On the properties of the international standards for tissue plasminogen activator